Edward Andrle
Direktor/Vorstandsmitglied bei NEUROONE MEDICAL TECHNOLOGIES CORPORATION
Vermögen: 71 283 $ am 30.04.2024
Aktive Positionen von Edward Andrle
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Direktor/Vorstandsmitglied | 18.02.2020 | - |
Independent Dir/Board Member | 18.02.2020 | - | |
Sorin Group Italia Srl
Sorin Group Italia Srl Medical SpecialtiesHealth Technology MicroPort CRM SRL engages in the production and distribution of medical devices. It specializes in the development of medical technologies for the treatment of cardiovascular diseases. The company is headquartered in Saluggia, Italy. | Corporate Officer/Principal | 01.01.2010 | - |
Karriereverlauf von Edward Andrle
Ehemalige bekannte Positionen von Edward Andrle
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LIVANOVA PLC | Corporate Officer/Principal | 01.09.2015 | 01.01.2020 |
SORIN SPA | Corporate Officer/Principal | 18.05.2011 | 01.09.2015 |
StarFire Medical, Inc.
StarFire Medical, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, StarFire Medical, Inc. is a company that manufactures therapeutic implantable devices. The company is based in Plymouth, MN. StarFire Medical was acquired by Nfocus Neuromedical, Inc. on March 06, 2008. | Vorstandsvorsitzender | 01.01.2002 | 01.01.2009 |
TERAMed, Inc.
TERAMed, Inc. Medical SpecialtiesHealth Technology Part of Cardinal Health, Inc., TERAMed, Inc. designs, develops, and manufactures endovascular graft systems. The company is based in Maple Grove, MN. TERAMed was acquired by Cordis Corp., part of Cardinal Health, Inc. from October 04, 2015 on December 18, 2001. | Vorstandsvorsitzender | 01.01.1996 | 01.01.2001 |
BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | 01.01.1991 | 01.01.1996 |
Myocor, Inc.
Myocor, Inc. Medical SpecialtiesHealth Technology Myocor, Inc. develops products for the treatment of mitral regurgitation and congestive heart failure. It has two products in clinical trials that are designed to improve the pumping efficiency of the heart and thus improve the quality of life of patients. The company was founded in 1996 by Cyril J. Schweich and Todd Mortier and is headquartered in Maple Grove, MN. | Vorstandsvorsitzender | - | - |
Gründer | - | - | |
MD Start SA
MD Start SA BiotechnologyHealth Technology MD Start SA develops medical device technology. It has collaboration between venture capital, institutional investors and industry to the development of innovative medtech ideas in Europe. The company was founded by Tim Lenihanin 2010 and is headquartered in Paris, France. | Direktor/Vorstandsmitglied | 10.05.2011 | - |
Ausbildung von Edward Andrle
University of Notre Dame | Undergraduate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 8 |
Italien | 3 |
Schweiz | 2 |
Operativ
Corporate Officer/Principal | 4 |
Chief Executive Officer | 3 |
Director/Board Member | 2 |
Sektoral
Health Technology | 10 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
LIVANOVA PLC | Health Technology |
BOSTON SCIENTIFIC CORPORATION | Health Technology |
NEUROONE MEDICAL TECHNOLOGIES CORPORATION | Health Technology |
Private Unternehmen | 6 |
---|---|
MD Start SA
MD Start SA BiotechnologyHealth Technology MD Start SA develops medical device technology. It has collaboration between venture capital, institutional investors and industry to the development of innovative medtech ideas in Europe. The company was founded by Tim Lenihanin 2010 and is headquartered in Paris, France. | Health Technology |
Sorin SpA
Sorin SpA Medical SpecialtiesHealth Technology Sorin SpA engages in the research, development, and manufacture of technology products for the treatment of cardiovascular diseases. It operates through the Cardiac Surgery and Cardiac Rhythm business segments. The Cardiac Surgery segment involves in the production and marketing of single-use biomedical devices, systems used to ensure out-of-body circulation in cardiac surgical procedures, and implantable prosthetics to replace or repair heart valves. The Cardiac Rhythm segment deals with the production and marketing of implantable devices and monitoring equipment and accessories to protect against heartbeat disorders. The company was founded in 1956 and is headquartered in Milan, Italy. | Health Technology |
Sorin Group Italia Srl
Sorin Group Italia Srl Medical SpecialtiesHealth Technology MicroPort CRM SRL engages in the production and distribution of medical devices. It specializes in the development of medical technologies for the treatment of cardiovascular diseases. The company is headquartered in Saluggia, Italy. | Health Technology |
StarFire Medical, Inc.
StarFire Medical, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, StarFire Medical, Inc. is a company that manufactures therapeutic implantable devices. The company is based in Plymouth, MN. StarFire Medical was acquired by Nfocus Neuromedical, Inc. on March 06, 2008. | Health Technology |
Myocor, Inc.
Myocor, Inc. Medical SpecialtiesHealth Technology Myocor, Inc. develops products for the treatment of mitral regurgitation and congestive heart failure. It has two products in clinical trials that are designed to improve the pumping efficiency of the heart and thus improve the quality of life of patients. The company was founded in 1996 by Cyril J. Schweich and Todd Mortier and is headquartered in Maple Grove, MN. | Health Technology |
TERAMed, Inc.
TERAMed, Inc. Medical SpecialtiesHealth Technology Part of Cardinal Health, Inc., TERAMed, Inc. designs, develops, and manufactures endovascular graft systems. The company is based in Maple Grove, MN. TERAMed was acquired by Cordis Corp., part of Cardinal Health, Inc. from October 04, 2015 on December 18, 2001. | Health Technology |
- Börse
- Insiders
- Edward Andrle
- Erfahrung